11-Jan-2019 | R | 21:100 Rights Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Krebs Biochemicals & Industries Ltd has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date.
COMPANY NAME & CODE
Krebs Biochemicals & Industries Ltd.
(524518)
RECORD DATE
01/02/2019
PURPOSE
Issue of 21 (Twenty One) equity shares of Rs.10/- each on rights basis for cash at premium of Rs.76/- per share for every 100 (Hundred) equity shares held.
Ex-Right basis from Date & Sett. No.
31/01/2019
DR-211/2018-2019
Trading Members of the Exchange are requested to take note of it.
(As Per NSE Notice Dated 14.01.2019) | 01-Feb-2019 | 21:100 |
15-Apr-2024 | BC | Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company. | 15-Apr-2024 | |
19-Jan-2024 | BC | KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Resul | 12-Feb-2024 | |
17-Jan-2024 | BC | The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members | 17-Jan-2024 | |
17-Jan-2024 | BC | The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members | 17-Jan-2024 | |
18-Oct-2023 | BC | KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve un-audited financial resu | 08-Nov-2023 | |
No Dividends has been declared by KREBSBIOCHEMICALSINDUSTRIES
No Bonus has been declared by KREBSBIOCHEMICALSINDUSTRIES
No Split has been declared by KREBSBIOCHEMICALSINDUSTRIES
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)76
Ratio21:100
Book Closure
15-Apr-2024 | - | Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company. |
12-Feb-2024 | - | KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Resul |
17-Jan-2024 | - | The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members |
17-Jan-2024 | - | The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members |
08-Nov-2023 | - | KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve un-audited financial resu |